Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1987;10:517-521

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kusaka, M.
Right arrow Articles by Sokabe, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kusaka, M.
Right arrow Articles by Sokabe, H.

Hypertension, Vol 10, 517-521, Copyright © 1987 by American Heart Association


ARTICLES

Does so-called streptozocin hypertension exist in rats?

M Kusaka, K Kishi and H Sokabe
Department of Pharmacology, Jichi Medical School, Tochigiken, Japan.

Although the existence of so-called streptozocin hypertension seems well established, some reports have indicated that no rise in blood pressure (BP) occurred after streptozocin treatments. To ascertain the streptozocin-induced BP response, normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) were treated with streptozocin, 40 to 45 and 35 mg/kg i.v., respectively, and BP was determined directly and indirectly every week for 3 to 4 weeks. Direct mean BP was determined without anesthesia or restraint through a cannula inserted into the rat's abdominal aorta. Indirect BP was determined at the tail without anesthesia after prewarming the rat in a holder. Compared with control values, indirect BP increased significantly in diabetic WKY 2 weeks after streptozocin treatment. In contrast, direct BP of these rats decreased, compared with control values. Indirect BP of diabetic SHR was as high as that of the controls, whereas direct BP of diabetic SHR decreased significantly 1 week after the treatment and thereafter, compared with control values. These discrepancies between the direct and indirect BP values may be caused by severe emaciation of diabetic rats. Extra pressure in the cuff may be necessary to occlude the bloodstream. These results indicate that under these conditions the value of BP obtained by the direct measurement is more reliable than that by the indirect one; therefore, we concluded that so-called streptozocin hypertension does not exist.


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
A. K. Bidani, M. Picken, R. Hacioglu, G. Williamson, and K. A. Griffin
Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F647 - F654.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. R. Nagareddy, Z. Xia, J. H. McNeill, and K. M. MacLeod
Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2144 - H2152.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Van Buren, C. M. Kasbergen, W. H. Gispen, and D. J. De Wildt
In vivo cardiovascular reactivity and baroreflex activity in diabetic rats
Cardiovasc Res, June 1, 1998; 38(3): 763 - 771.
[Abstract] [Full Text] [PDF]